Serum-Level Changes of Vascular Endothelial Growth Factor in Children with Infantile Hemangioma after Oral Propranolol Therapy

Infantile Hemangioma--Mechanism(s) of Drug Action on a Vascular Tumor

(2013) S. Greenberger et al.   Cold Spring Harbor Perspectives in Medicine

Recurrence of Infantile Hemangiomas Treated with Propranolol

(2011) Lorea Bagazgoitia et al.   PEDIATRIC DERMATOLOGY

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

(2010) C.H. Storch et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas

(2010) Clemens Schiestl et al.   EUROPEAN JOURNAL OF PEDIATRICS

Expression of components of the renin–angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution

(2010) Tinte Itinteang et al.   Journal of Plastic Reconstructive and Aesthetic Surgery

Local serum levels of vascular endothelial growth factor in infantile hemangioma: Intriguing mechanism of endothelial growth

(2009) Przemysław Przewratil et al.   CYTOKINE

Serum Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Children with Hemangiomas and Vascular Malformations-Preliminary Report

(2009) Przemyslaw Przewratil et al.   PEDIATRIC DERMATOLOGY

Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion

(2009) Borhane Annabi et al.   PHARMACOLOGICAL RESEARCH

Propranolol for Severe Hemangiomas of Infancy

(2008) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE

Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical Literature

(2008) Christine Kilcline et al.   PEDIATRIC DERMATOLOGY